719 results on '"Daly, Norelle L."'
Search Results
102. Conotoxin Φ‐MiXXVIIA from the Superfamily G2 Employs a Novel Cysteine Framework that Mimics Granulin and Displays Anti‐Apoptotic Activity
103. Solving the [alpha]-conotoxin folding problem: efficient selenium-directed on-resin generation of more potent and stable nicotinic acetylcholine receptor antagonists
104. Retrocyclin-2: structural analysis of a potent anti-HIV [theta]-defensin
105. Isolation, solution structure, and insecticidal activity of kalata B2, a circular protein with a twist: Do Mobius strips exist in nature?
106. An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease
107. Development of a Potent Wound Healing Agent Based on the Liver Fluke Granulin Structural Fold
108. The N‐terminal pro‐domain of the kalata B1 cyclotide precursor is intrinsically unstructured
109. Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone
110. Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activity
111. Disulfide Bridges: Bringing Together Frustrated Structure in a Bioactive Peptide
112. Efficient backbone cyclization of linear peptides by a recombinant asparaginyl endopeptidase
113. Cyclic thrombospondin-1 mimetics: grafting of a thrombospondin sequence into circular disulfide-rich frameworks to inhibit endothelial cell migration
114. Transforming conotoxins into cyclotides: Backbone cyclization of P-superfamily conotoxins
115. The Aromatic Head Group of Spider Toxin Polyamines Influences Toxicity to Cancer Cells.
116. Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities
117. Design of substrate-based BCR-ABL kinase inhibitors using the cyclotide scaffold
118. A Defined α-Helix in the BifunctionalO-Glycosylated Natriuretic Peptide TcNPa from the Venom ofTropidechis carinatus
119. Solution Structure, Aggregation Behavior, and Flexibility of Human Relaxin-2
120. Backbone Cyclization Improves the Enzymatic Stability of χ-Conotoxin, MrIA, whilst Maintaining its Structure and NET-Modulating Activity
121. Solution Structure, Membrane Interactions, and Protein Binding Partners of the Tetraspanin Sm-TSP-2, a Vaccine Antigen from the Human Blood Fluke Schistosoma mansoni
122. A Tarantula-Venom Peptide Antagonizes the TRPA1 Nociceptor Ion Channel by Binding to the S1–S4 Gating Domain
123. The C-terminal propeptide of a plant defensin confers cytoprotective and subcellular targeting functions
124. Erratum: The self‐association of the cyclotide kalata B2 in solution is guided by hydrophobic interactions
125. Structural Insights into the Role of the Cyclic Backbone in a Squash Trypsin Inhibitor
126. Correction to Chemical Re-engineering of Chlorotoxin Improves Bioconjugation Properties for Tumor Imaging and Targeted Therapy
127. Novel Inhibitor Cystine Knot Peptides from Momordica charantia
128. CHAPTER 2 - NMR of Peptide Toxins
129. Vicinal Disulfide Constrained Cyclic Peptidomimetics: a Turn Mimetic Scaffold Targeting the Norepinephrine Transporter
130. Isolation of an Orally Active Insecticidal Toxin from the Venom of an Australian Tarantula
131. The self‐association of the cyclotide kalata B2 in solution is guided by hydrophobic interactions
132. Anthelminthic activity of the cyclotides (kalata B1 and B2) against schistosome parasites
133. High-affinity Cyclic Peptide Matriptase Inhibitors
134. Cyclization of the Antimicrobial Peptide Gomesin with Native Chemical Ligation: Influences on Stability and Bioactivity
135. Cyclic thrombospondin-1 mimetics: grafting of a thrombospondin sequence into circular disulfide-rich frameworks to inhibit endothelial cell migration.
136. Design, Synthesis, Structural and Functional Characterization of Novel Melanocortin Agonists Based on the Cyclotide Kalata B1
137. The three-dimensional structure of the analgesic α-conotoxin, RgIA
138. Gly6 of kalata B1 is critical for the selective binding to phosphatidylethanolamine membranes
139. Phosphatidylethanolamine Binding Is a Conserved Feature of Cyclotide-Membrane Interactions
140. Characterizing circular peptides in mixtures: sequence fragment assembly of cyclotides from a violet plant by MALDI-TOF/TOF mass spectrometry
141. ChemInform Abstract: Cystine Knot Folding in Cyclotides
142. Quantification of small cyclic disulfide‐rich peptides
143. Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds
144. Cover Picture: A Synthetic Mirror Image of Kalata B1 Reveals that Cyclotide Activity Is Independent of a Protein Receptor (ChemBioChem 16/2011)
145. Cyclotides: a patent review
146. Identification and Characterization of a New Family of Cell-penetrating Peptides
147. A Synthetic Mirror Image of Kalata B1 Reveals that Cyclotide Activity Is Independent of a Protein Receptor
148. α-Conotoxin ImI Incorporating Stable Cystathionine Bridges Maintains Full Potency and Identical Three-Dimensional Structure
149. Effects of Cyclization on Stability, Structure, and Activity of α-Conotoxin RgIA at the α9α10 Nicotinic Acetylcholine Receptor and GABAB Receptor
150. Isolation and characterization of cytotoxic cyclotides from Viola philippica
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.